Respiratory
diseases are infections of airways and other parts including disorders of
bronchi, respiratory tract, alveoli, nerves and tissues involved in
respiration. Respiratory disorders vary from mild conditions such as cold to
severe life threatening conditions such as bacterial pneumonia and lung cancer.
Respiratory disorders are characterized by mild to severe chest pain, cough,
hemoptysis, and breathlessness. Owing to large surface area, respiratory tract
is continuously exposed to large number of microorganisms. However, respiratory
tract have ability to induce self-preventive mechanism to prevent entry of any
foreign microbes into the body through respiratory passage. Some of the common
respiratory disorders include chronic obstructive pulmonary disease (COPD),
chronic bronchitis, asthma, and pneumonia. These respiratory diseases and
allergies including asthma are caused due to continuous exposure to air dust
particles, inadequate development and function of lungs before or during
childhood, genetic factors such as elevated level of certain enzymes (IgE), and
low immune response and functioning of immune system.
These
chronic respiratory disorders are not completely curable, though they can be
minimized by various available forms of treatment including use of devices such
as oxygen concentrators, liquid oxygen, and oxygen pumps. Acetyl cysteine
medication and pulmozyme inhalers are also effective in treating respiratory
disorders. A well balanced diet help to boost immune system leading to increase
immune response of the body to various external pathogenic organisms thereby
having positive impact on the overall health of an individual. Severe forms of
COPD and asthma require long term treatments including use of mechanical
ventilation for providing adequate oxygen and use of ipratropium drugs for
treating acute asthma. Moreover, long term monitoring is very much essential
for treatment and management of various respiratory disorders.
Request
for an in-depth table of contents for this report @ https://www.crystalmarketresearch.com/request-toc/upcoming/HC0656
Increasing
geriatric population, rise in incidences of chronic respiratory diseases,
sedentary lifestyle and rise in air pollution level is expected to increase the
demand for respiratory care devices. Number of people with aged 60 and more has
increased substantially in the past few years. According to United Nations
(UN), aging population is expected to grow at 56% from 901 million in 2015 to
1.4 billion by 2050. Increasing elderly population is at high risk of
developing respiratory infections owing to decrease immune response and
anatomical changes in the lungs. Another major factor responsible for increase
demand for respiratory care devices is increasing incidence of chronic
respiratory diseases such as COPD and asthma. According to a report published
by Global Asthma Network in 2014, around 334 million people worldwide were
suffering from asthma and this number is expected to increase by 100 million in
2025. Such high prevalence of asthma will drive the growth of the respiratory
care devices market. However, certain side effects such as morning headaches
and fatigue associated with long term use of respiratory devices, dearth of
awareness about respiratory disorders, and availability of alternative treatment
options (medications) can hamper the growth of the global market for
respiratory care devices.
Currently,
major players operating in the global market are focusing on developing highly
advanced smart end devices to provide effective and timely treatment. With
rapid ongoing developments related to homecare devices, medical care is no more
only confined to clinics and laboratories. Healthcare infrastructure is rapidly
changing owing to introduction of new technologies such as web based
interaction and telemedicine that enable remote contact between patients and
healthcare providers. These advanced technological developments will increase
demand for highly sophisticated respiratory care devices thereby providing
large number of growth opportunities for key players.
Make
an inquiry @ https://www.crystalmarketresearch.com/send-an-enquiry/HC0656
The
major players in the global respiratory care device market include Hamilton
Medical AG, Drägerwerk AG & Co. KGaA, Becton, Dickinson and Company,
Philips Healthcare, Medtronic plc., Masimo Corporation, ResMed, Inc., and
Fisher & Paykel Healthcare. Technological innovations and new product
development is the key strategy adopted by these players to expand and
strengthen their product portfolio in order to sustain in this market at global
level. For instance, in May 2017, Fisher & Paykel Healthcare launched new
CPAP device used in treatment of obstructive sleep apnea. This device has
built-in Bluetooth connectivity option to ensure both patients and healthcare
professionals will receive vital information whenever required. This device
will be available in New Zealand and Australia from June 2017.
About Crystal Market Research
Crystal Market Research is
a U.S. based market research and business intelligence company. Crystal offers
one stop solution for market research, business intelligence, and consulting
services to help clients make more informed decisions. It provides both syndicated
as well as customized research studies for its customers spread across the
globe. The company offers market intelligence reports across a broad range of
industries including healthcare, chemicals & materials, technology,
automotive, and energy.
Contact:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Website:
http://www.crystalmarketresearch.com
No comments:
Post a Comment